Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10016)
All Articles published online
|
Publishing Process of This Article
|
May 16, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Endoscopy
ISSN
1948-5190
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abid S, Ali S, Baig MA, Waheed AA. Is it time to replace propranolol with carvedilol for portal hypertension? World J Gastrointest Endosc 2015; 7(5): 532-539 [PMID: 25992192 DOI: 10.4253/wjge.v7.i5.532] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v7/i5/532.htm |
| Number | Citing Articles |
| 1 |
Samira Ben Brahim, Daniel Hartmann, Michael W. Müller, Helmut Friess. Viszerale Operationen bei Patienten mit Leberzirrhose - was ist zu beachten?. Gastro-News 2020; 7(5): 45 doi: 10.1007/s15036-020-1371-0
|
| 2 |
Qi Zhang, Xin Wang, Hongjiao Xue, Baolin Huang, Zimin Lin, Zheng Cai. Determination and Comparison of the Solubility, Oil–Water Partition Coefficient, Intestinal Absorption, and Biliary Excretion of Carvedilol Enantiomers. AAPS PharmSciTech 2021; 22(1) doi: 10.1208/s12249-020-01906-7
|
| 3 |
Jin-Feng Yang, Neng Cheng, Sheng Ren, Xiang-Ming Liu, Xian-Tao Li. Characterization and molecular basis for the block of Kv1.3 channels induced by carvedilol in HEK293 cells. European Journal of Pharmacology 2018; 834: 206 doi: 10.1016/j.ejphar.2018.07.025
|
| 4 |
Muhammad Sohail, . Kamran, Muhammad Sajjad Khan, Zainab Irshad, Muhammad Fahim, Sundus Naeem, Inam Ullah, Syeda Rubina Gillani. Carvidelol Vs Propanol for Secondary Prophylaxis of Variceal Hemorrhage in Liver Cirrhosis Patients . Pakistan Journal of Health Sciences 2023; : 62 doi: 10.54393/pjhs.v4i04.686
|
| 5 |
Mohamed Balaha, Samah Kandeel, Waleed Barakat. Carvedilol suppresses circulating and hepatic IL-6 responsible for hepatocarcinogenesis of chronically damaged liver in rats. Toxicology and Applied Pharmacology 2016; 311: 1 doi: 10.1016/j.taap.2016.10.012
|
| 6 |
Takashi Tajiri, Hiroshi Yoshida, Hiroshi Makino, Atsushi Hirakata, Junji Ueda, Hideyuki Takata, Yasuhiro Mamada, Nobuhiko Taniai, Eiji Uchida. Clinical Investigation of Portal Hypertension. 2019; : 593 doi: 10.1007/978-981-10-7425-7_61
|
| 7 |
Eula Plana Tetangco, Rogelio G. Silva, Edgar V. Lerma. Portal hypertension: Etiology, evaluation, and management. Disease-a-Month 2016; 62(12): 411 doi: 10.1016/j.disamonth.2016.08.001
|
| 8 |
Karn Wijarnpreecha, Fang Li, Yang Xiang, Xun Xu, Cong Zhu, Vahed Maroufy, Qing Wang, Wei Tao, Yifang Dang, Huy Anh Pham, Yujia Zhou, Jianfu Li, Xinyuan Zhang, Hua Xu, C. Burcin Taner, Liu Yang, Cui Tao. Nonselective beta‐blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Alimentary Pharmacology & Therapeutics 2021; 54(4): 481 doi: 10.1111/apt.16490
|
| 9 |
Chantelli Iamblaudiot Razafindrazoto, Lova Dany Ella Razafindrabekoto, Domoina Harivonjy Hasina Laingonirina, Raveloson Raveloson, Anjaramalala Sitraka Rasolonjatovo, Andry Lalaina Rinà Rakotozafindrabe, Tovo Harimanana Rabenjanahary, Soloniaina Hélio Razafimahefa, Rado Manitrala Ramanampamonjy. Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety. JGH Open 2022; 6(3): 213 doi: 10.1002/jgh3.12721
|
| 10 |
Ji-Yao Sheng, Zi-Fan Meng, Qiao Li, Yong-Sheng Yang. Recent advances in promising drugs for primary prevention of gastroesophageal variceal bleeding with cirrhotic portal hypertension. Hepatobiliary & Pancreatic Diseases International 2024; 23(1): 4 doi: 10.1016/j.hbpd.2023.08.003
|
| 11 |
Salma N Fahmy, Lobna H Khedr, Sara A Wahdan, Esther T Menze, Samar S Azab, Ebtehal El-Demerdash. Effect of carvedilol on pharmacokinetics of sofosbuvir and its metabolite GS-331007: role of P-glycoprotein. Journal of Pharmacy and Pharmacology 2024; 76(8): 1051 doi: 10.1093/jpp/rgae070
|
| 12 |
Ruiqi Xia, Bing Wu, Ji Zhou, Mingyan Ji, Shuyue Wang, Xiaoqing Zeng, Shiyao Chen. Ascites affects the benefit of carvedilol on patients with liver cirrhosis and esophageal and gastric varices. Clinical and Translational Science 2024; 17(7) doi: 10.1111/cts.13889
|